Shire describes dealing with a changeable merger

Jul 06, 2015
<p><span>Highlights from the IR Magazine Awards &ndash; Europe 2015</span></p>

Sarah Elton-Farr, senior director of investor relations at biotech firm Shire, discusses the difficulties of a changing merger deal and how she and her team kept investors informed.

As a firm, Shire was nominated for three trophies at the IR Magazine Awards - Europe 2015 and came away with the best in region award for the UK & Ireland.

Sign up to get stories direct to your inbox
logo-black logo-black